Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 109 | 131 | 72 | 55 | 47 |
| Gross Profit | 109 | 131 | 72 | 55 | 47 |
| Operating Expenses | 2,070 | 2,100 | 5,528 | 2,313 | 2,341 |
| Operating Income | -1,961 | -1,969 | -5,456 | -2,258 | -2,294 |
| Interest Expense | 2 | 102 | 5,012 | 50 | 49 |
| Other Income | 6 | 23 | 0 | 0 | 0 |
| Pre-tax Income | -1,957 | -2,048 | -10,468 | -2,308 | -2,343 |
| Net Income Continuous | -1,957 | -2,048 | -10,468 | -2,308 | -2,343 |
| Net Income | $-1,957 | $-2,048 | $-10,468 | $-2,308 | $-2,343 |
| EPS Basic Total Ops | -0.14 | 0.10 | -0.81 | -0.49 | -0.86 |
| EPS Basic Continuous Ops | -0.14 | 0.07 | -0.81 | -0.49 | -0.81 |
| EPS Diluted Total Ops | -0.14 | 0.10 | -0.81 | -0.49 | -0.86 |
| EPS Diluted Continuous Ops | -0.14 | 0.07 | -0.81 | -0.49 | -0.81 |
| EBITDA(a) | $-1,958 | $-1,967 | $-5,453 | $-2,256 | $-2,276 |